Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Veeva Systems (NYSE:VEEV) had its price objective raised by equities research analysts at Robert W. Baird from $314.00 to $319.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the technology company’s stock. Robert W. Baird’s price target suggests a potential upside of 30.79% from the stock’s current price.

Several other brokerages also recently issued reports on VEEV. BMO Capital Markets began coverage on Veeva Systems in a report on Thursday, November 13th. They issued a “market perform” rating and a $300.00 price target for the company. Raymond James Financial restated an “outperform” rating and set a $340.00 price objective (up previously from $310.00) on shares of Veeva Systems in a report on Thursday, August 28th. Truist Financial upped their target price on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a research report on Thursday, August 28th. Wells Fargo & Company lifted their price target on shares of Veeva Systems from $300.00 to $326.00 and gave the company an “overweight” rating in a report on Tuesday, August 26th. Finally, Canaccord Genuity Group upped their price objective on Veeva Systems from $270.00 to $300.00 and gave the company a “hold” rating in a research note on Thursday, August 28th. Seventeen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $308.64.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $243.91 on Friday. Veeva Systems has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The company has a market cap of $39.98 billion, a PE ratio of 50.07, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The firm has a fifty day moving average price of $288.39 and a two-hundred day moving average price of $278.47.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.95 by $0.09. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The business had revenue of $811.24 million for the quarter, compared to analyst estimates of $792.37 million. During the same quarter in the previous year, the firm earned $1.75 EPS. Veeva Systems’s quarterly revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS. Q4 2026 guidance at 1.920-1.920 EPS. Analysts expect that Veeva Systems will post 4.35 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP Jonathan Faddis sold 14,595 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president owned 8,588 shares of the company’s stock, valued at $2,576,400. This represents a 62.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Thomas D. Schwenger sold 3,350 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider owned 23,773 shares in the company, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 over the last ninety days. 10.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Veeva Systems

Institutional investors and hedge funds have recently made changes to their positions in the business. ASR Vermogensbeheer N.V. lifted its stake in Veeva Systems by 64.2% in the second quarter. ASR Vermogensbeheer N.V. now owns 5,167 shares of the technology company’s stock worth $1,488,000 after acquiring an additional 2,020 shares during the period. QRG Capital Management Inc. raised its position in shares of Veeva Systems by 15.7% in the second quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock worth $3,678,000 after acquiring an additional 1,735 shares during the period. Merit Financial Group LLC increased its stake in shares of Veeva Systems by 12.5% during the second quarter. Merit Financial Group LLC now owns 45,247 shares of the technology company’s stock worth $13,030,000 after purchasing an additional 5,042 shares in the last quarter. Nordea Investment Management AB boosted its position in Veeva Systems by 9.3% during the second quarter. Nordea Investment Management AB now owns 391,273 shares of the technology company’s stock worth $110,832,000 after acquiring an additional 33,378 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its holdings in shares of Veeva Systems by 1.9% during the 2nd quarter. Teacher Retirement System of Texas now owns 143,469 shares of the technology company’s stock worth $41,316,000 after acquiring an additional 2,659 shares during the period. Hedge funds and other institutional investors own 88.20% of the company’s stock.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.